- Why Research
- Our Impact
- Get Involved
- About BCRF
- Contact Us
- Cancer Divides. We Unite.
You are here
Hedvig Hricak, MD, PhD
Member, Molecular Pharmacology & Chemistry Program
Professor, Gerstner Sloan Kettering Graduate School
Chairman, Department of Radiology
Memorial Sloan Kettering Cancer Center
New York, New York
Seeking to standardize best practices in breast cancer imaging and interpretation to advance clinical management of breast cancer worldwide.
An international program in breast cancer imaging trains radiologists from around the world in breast imaging interpretation and clinical research.
A global network of breast imaging radiologists is working together with the single goal of improving breast cancer patient outcomes worldwide.
With BCRF support since 2004, Dr. Hricak and colleagues in the Department of Radiology at Memorial Sloan Kettering Cancer Center have established and maintained a global, world-class clinical research training program in breast imaging. This program provides selected radiologists from around the world with intensive, individualized instruction in breast imaging interpretation and clinical research methodology with the goal of standardizing best practices and fostering international collaborations to improve patient care and outcomes.
Dr. Hricak has established important connections in 14 countries and regions to provide the most promising candidates for future training. In the last year, Dr. Hricak led a breast imaging meeting in Shanghai, China, which provided a forum for current research and future needs. Her team also met with leadership from India to develop a breast imaging symposium for radiologists in India.
These collaborations have led to programs in breast cancer screening and magnetic resonance-guided biopsy, and the development of new technologies in breast imaging. In the upcoming year, Dr. Hricak and team will train a BCRF Fellow who will participate in cutting-edge research combining imaging and genomics studies, which are designed to help clinicians distinguish deadly breast cancer from indolent breast cancer.
Hedvig Hricak is Chair of the Department of Radiology, Memorial Sloan Kettering Cancer Center, a member of the Molecular Pharmacology and Chemistry Program, Sloan Kettering Institute, and Professor, Gerstner Sloan Kettering Graduate School of Biomedical Sciences. The hallmark of her research career has been the validation of new imaging technologies and their translation into clinical practice, with a special emphasis on oncology. She is particularly renowned for pioneering the application of MRI to prostate and gynecological cancers. Her extensive publication record includes more than 380 peer-reviewed original research articles and over 135 monographs and book chapters. She is a member of the Institute of Medicine of the National Academy of Sciences and a "foreign" member of the Croatian Academy of Arts and Sciences and the Russian Academy of Science. She has served on the Scientific Advisory Board of the National Cancer Institute, the Advisory Council of the National Institute of Biomedical Imaging and Bioengineering, and the Nuclear and Radiation Studies Board of the NAS. She has long been committed to promoting education and international collaboration in imaging. With support from BCRF and NCI, she established a global program for training in breast cancer imaging and research. She is also PI of the NIH/NCI R25T program "Molecular Imaging: Training for Oncology," as well as MSKCC co-PI of the training section of the CCNY-MKSCC Partnership grant for underrepresented undergraduate and graduate students and postdoctoral trainees. Her numerous honors and awards include an honorary doctorate from the Ludwig Maximilian University, Munich.
BCRF Investigator Since
The Delta Air Lines Award